Loading data
CTGONYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Operating profit | 69.08 m USD | 26.28 m USD | -33.1 m USD | -38.77 m USD | — |
| Profit before tax | -35.78 m USD | -38.11 m USD | -59.11 m USD | -39.74 m USD | — |
| Income tax expense | 303.24 k USD | -83.4 k USD | 0 USD | 0 USD | — |
| Net income (reported basis) | -36.09 m USD | -38.03 m USD | -39.74 m USD | -39.74 m USD | -23.51 m USD |
| Net income attributable to common shareholders | -36.09 m USD | -38.03 m USD | — | — | — |
| Basic earnings per share | -2.8 USD/share | -3.49 USD/share | -7.14 USD/share | -5.61 USD/share | — |
| Diluted earnings per share | -2.8 USD/share | -3.49 USD/share | -7.14 USD/share | -5.61 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.